PDL BioPharma News
Most Popular PDL BioPharma Story
Biotech CEOs face rising fury of angry investors
The San Francisco Chronicle reports that a growing number of biotech execs have had to ward off the angry attacks of shareholder activists who protest the way they're running their companies.... Read more...
Latest Headlines
- January 7, 2009
- December 22, 2008
- December 5, 2008
- August 20, 2008
- April 11, 2008
- October 2, 2007
- August 29, 2007
- August 21, 2007
- July 26, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
